| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.05 |